Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 251–300 of 3,853 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06414317	An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers	active not recruiting	N/A	12	Roswell Park Cancer InstituteOTHER	1	Aug 25, 2026	clinicaltrials
NCT07579195	Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial	recruiting	Phase 1 / Phase 2	12	University of WashingtonOTHER	1	Aug 25, 2026